Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis

Background: Minimal residual disease (MRD) has shown the prognostic value in mantle cell lymphoma (MCL). To quantify the relationships between progression free survival (PFS) and overall survival (OS) with MRD status in MCL, we conducted this meta-analysis. Methods: We searched databases including P...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu, Chen, Haizhu, Tao, Yunxia, Zhong, Qiaofeng, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738989/
https://www.ncbi.nlm.nih.gov/pubmed/33391451
http://dx.doi.org/10.7150/jca.51959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738989/
https://www.ncbi.nlm.nih.gov/pubmed/33391451
http://dx.doi.org/10.7150/jca.51959

Ejemplares similares